ARYZTA (ARYN) Q3 2025 TU earnings summary
Event summary combining transcript, slides, and related documents.
Q3 2025 TU earnings summary
20 Oct, 2025Executive summary
Q3 organic growth reached 0.8%, driven by 1.0% pricing and flat volume, with year-to-date organic growth at 2.1% supported by both volume/mix and pricing.
Innovation contributed approximately 18% of year-to-date revenue, with new capacity investments in Malaysia, Switzerland, Germany, and Australia.
All channels contributed to growth, with bake-off gaining market share from fresh bakery.
Cost optimisation programmes are being accelerated to address higher-than-expected labour and input cost inflation.
Leadership reiterates confidence in achieving mid-term targets for 2028, emphasizing a strong track record and ongoing innovation.
Financial highlights
Q3 group revenue was €554.3m, with Europe contributing €492.8m and Rest of World €61.5m.
Nine-month group revenue reached €1,640.7m, up 2.1% year-over-year, with Europe at €1,461.4m and Rest of World at €179.3m.
Q3 organic growth: Europe 0.7%, Rest of World 1.4%, Group 0.8%; nine-month: Europe 2.2%, Rest of World 1.8%, Group 2.1%.
EBITDA for 2025 is confirmed at a minimum of €300 million, with free cash flow around €100 million.
Outlook and guidance
Full-year 2025 guidance: organic growth in the low to mid-single-digit range, EBITDA at least €300 million, and free cash flow about €100 million.
Mid-term targets (2025-2028): revenue growth above market, EBITDA margin >15%, EBIT margin >9%, CAPEX at 3.5-4.5% of revenue, and net debt leverage at 1.5-2x.
Acceleration of cost optimisation measures is expected to drive a swift rebound in performance and profitability.
Further details on capital return to shareholders will be provided in 2026.
Latest events from ARYZTA
- Revenue, EBITDA, and cash flow rose; capital return policy and bond repurchase set for 2026.ARYN
Q4 20252 Mar 2026 - EBITDA margin rose to 14.2% on €1,055.2m revenue, with leverage down to 2.9x.ARYN
H1 20241 Feb 2026 - FY2025 targets exceeded, with strong EBITDA, cash flow, and major investment in Portugal.ARYN
Q4 2025 TU22 Jan 2026 - EBITDA guidance reset to €300m for 2025; interim CEO appointed to drive improvements.ARYN
Investor Update14 Dec 2025 - Midterm targets met early, with higher margins, strong cash flow, and double-digit EPS growth.ARYN
H2 202410 Dec 2025 - Revenue and EPS rose, with margin pressured by inflation but guidance reaffirmed.ARYN
H1 202523 Nov 2025 - Targets above-market growth and >15% EBITDA margin by 2028 through innovation and efficiency.ARYN
CMD 202517 Nov 2025 - Innovation-led growth, margin expansion, and strong cash flow drive ARYZTA's robust performance.ARYN
Investor Presentation13 Jun 2025 - Q3 organic growth rebounded to 2.0%, with strong volumes and cost-saving initiatives underway.ARYN
Q3 2024 TU13 Jun 2025